Heparin or Enoxaparin in Patients With Cancer
Completed
Conditions studied: Lymphoma, Thromboembolism, Unspecified Adult Solid Tumor, Protocol Specific
In brief
RATIONALE: Heparin or enoxaparin may be effective in preventing the formation of blood clots in patients with cancer who are undergoing surgery to remove the tumor. PURPOSE: Randomized clinical trial to compare the effectiveness of heparin with that of enoxaparin in patients who have cancer.
Key facts
- Study ID
- NCT00004875
- Run by
- Northwestern University
- People needed
- 6
- Starts
- 1996-07-01
- Expected to finish
- 1999-03-01
- Last updated by the study team
- 2011-02-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Veterans Affairs Medical Center - Chicago (Lakeside) — Chicago, Illinois, United States
- Evanston Northwestern Health Care — Evanston, Illinois, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.